{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:27:55Z","timestamp":1783042075601,"version":"3.54.6"},"reference-count":72,"publisher":"Informa UK Limited","issue":"7","funder":[{"name":"funded by Lek\/Sandoz"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2019,7,3]]},"DOI":"10.1080\/13543776.2019.1627327","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T15:25:41Z","timestamp":1559402741000},"page":"487-496","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["A literature review of the patent publications on venetoclax \u2013 a selective Bcl-2 inhibitor: discovering the therapeutic potential of a novel chemotherapeutic agent"],"prefix":"10.1080","volume":"29","author":[{"given":"Nina","family":"\u017digart","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia"},{"name":"Analytics Department, Lek Pharmaceuticals d.d., Sandoz Development Center Slovenia, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenko","family":"\u010casar","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia"},{"name":"Analytics Department, Lek Pharmaceuticals d.d., Sandoz Development Center Slovenia, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,6,7]]},"reference":[{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2007-0228"},{"key":"CIT0009","unstructured":"European Medicines Agency. Venclyxto (venetoclax) EPAR: An overview of Venclyxto and why it is authorised in the EU; 2018."},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1126\/science.6093263"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.23"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1972.33"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/1-4020-2217-4_2","author":"Petch A","year":"2004","journal-title":"Cell Eng"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.50"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.183"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.179"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.170"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.186"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.161"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b01888"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2010.149"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.188"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/1-4020-2217-4_9","author":"Beauparlant P","year":"2004","journal-title":"Cell Eng"},{"key":"CIT0024","first-page":"5407","volume":"52","author":"Miyashita T","year":"1992","journal-title":"Cancer Res"},{"key":"CIT0025","first-page":"1077","volume":"7","author":"Manion MK","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S109325"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1038\/nature03579"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-098012"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5836"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70261-8"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3048"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.01.018"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1177\/1060028016685803"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2017.12.001"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12457"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2018.02.002"},{"key":"CIT0039","unstructured":"Elmore S, Souers A, Wang LC, et al. Methods of treatment using selective BCL-2 inhibitors. WO 2012\/071374 A1. 2012."},{"key":"CIT0040","unstructured":"Catron ND, Chen S, Gong Y, et al. Salts and crystalline forms of an apoptosis-inducing agent. WO 2012\/071336 A1. 2012."},{"key":"CIT0041","unstructured":"Barkalow J, Califano J-C, Chan VS, et al. Processes for the preparation of an apoptosis-inducing agent. WO 2014\/165044 A1. 2014."},{"key":"CIT0042","unstructured":"Ge M, Xu YL. [Synthesis of Bcl-2 inhibitor ABT-199]. CN 104370905 B. 2016."},{"key":"CIT0044","unstructured":"Birtalan E, Hoelig P, Lindley DJ, et al. Melt-extruded solid dispersions containing an apoptosis-inducing agent. WO 2012\/121758 A1. 2012."},{"key":"CIT0045","unstructured":"Catron ND, Lindley DJ, Miller J, et al. Solid dispersions containing an apoptosis-inducing agent. WO 2012\/058392 A1. 2012."},{"key":"CIT0046","unstructured":"Bruncko M, Ding H, George DA, et al. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases. US 9,174,982 B2. 2015."},{"key":"CIT0047","unstructured":"Bruncko M, Ding H, Doherty G, et al. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases. EP 2 435 432 B1. 2015."},{"key":"CIT0048","unstructured":"Bruncko M, Ding H, Doherty G, et al. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases. EP 2 576 546 B1. 2015."},{"key":"CIT0049","unstructured":"Bernstein BE, Aster JC, Bradner JE, et al. Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy. WO 2013\/192274 A9. 2013."},{"key":"CIT0051","doi-asserted-by":"crossref","unstructured":"Eastman AR, Bates D. Method for treating chronic lymphocytic leukemia. WO 2015\/149105 A1. 2015.","DOI":"10.1007\/978-3-642-27841-9_1153-2"},{"key":"CIT0052","unstructured":"Strack P, Booher R. Method for treating cancer. WO 2015\/130585 A1. 2015."},{"key":"CIT0054","unstructured":"He W. Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases. WO 2017\/218844 A2. 2017."},{"key":"CIT0055","unstructured":"Starczynowski D, Rhyasen GW. Combination therapy for MDS. WO 2014\/190163 A2. 2014."},{"key":"CIT0057","unstructured":"Starczynowski D, Rhyasen GW. Combination therapy for MDS. US 9,168,257 B2. 2015."},{"key":"CIT0058","unstructured":"Starczynowski D, Rhyasen GW. Combination therapy for MDS. EP 2 999 470 B1. 2017."},{"key":"CIT0061","unstructured":"Walensky LD. Inhibition of MCL-1 and\/or BFL-1\/A1. WO 2013\/142281 A1. 2013."},{"key":"CIT0063","unstructured":"Walensky LD. Inhibition of MCL-1 and\/or BFL-1\/A1. AU 2013235425 B2. 2017."},{"key":"CIT0064","unstructured":"Hill O, Gieffers C, Thiemall M, et al. Single-chain TRAIL-receptor agonist proteins. WO 2015\/164588 A1. 2015."},{"key":"CIT0065","unstructured":"Marchini A, Li J, Schroeder L, et al. Cancer therapy with a parvovirus combined with a BCL-2 inhibitor. WO 2015\/010782 A1. 2015."},{"key":"CIT0067","doi-asserted-by":"crossref","unstructured":"Marchini A, Li J, Schroeder L, et al. Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor. EP 3 024 491 B1. 2017.","DOI":"10.18609\/cgti.2017.016"},{"key":"CIT0068","unstructured":"Marchini A, Li J, Schroeder L, et al. Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor. JP 6195988 B2. 2017."},{"key":"CIT0069","unstructured":"Marchini A, Li J, Schroeder L, et al. Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor. AU 2014295442 B2. 2017."},{"key":"CIT0070","unstructured":"Crawford J, Wei B, Young WB. Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality. WO 2015\/082583 A1. 2014."},{"key":"CIT0071","unstructured":"Link AJ, Zhang S. Novel engineered potent cytotoxic stapled BH3 peptides. WO 2013\/116829 A1. 2013."},{"key":"CIT0073","unstructured":"Reilly EB, Phillips AC, Benatuil L, et al. Anti-EGFR antibodies and antibody drug conjugates. WO 2015\/143382 A1. 2015."},{"key":"CIT0074","doi-asserted-by":"crossref","unstructured":"Bialucha CU, Collins S, Hu T, et al. Anti-CDH6 antibody drug conjugates. WO 2016\/024195 A1. 2016.","DOI":"10.1002\/9781119060727.ch1"},{"key":"CIT0075","unstructured":"Sun LL, Chen YM-Y, Dennis MS, et al. Anti-CD79b antibodies and methods of use. WO 2016\/090210 A1. 2016."},{"key":"CIT0076","unstructured":"Walsh K, de Almeida P, Du C, et al. Combination therapy comprising anti-angiogenesis agent and OX40 binding antibodies. WO 2015\/153514 A1. 2015."},{"key":"CIT0077","unstructured":"Du C, Kim J, Zhu J, et al. Anti-OX40 antibodies and methods of use. WO 2015\/153513 A1. 2015."},{"key":"CIT0078","first-page":"1123","volume":"12","author":"Madhok R","year":"2015","journal-title":"BMJ Clin Evid"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.122037"},{"key":"CIT0080","unstructured":"Laberge R-M, Campisi J, Davalos A, et al. Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders. WO 2015\/116740 A1. 2015."},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.07.003"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11190"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2015.17"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.253"},{"key":"CIT0086","unstructured":"Bhushan A. Inhibiting senescent processes in beta cells for the prevention of type 1 diabetes. WO 2018\/204830 A2. 2018."},{"key":"CIT0087","unstructured":"Li F, Li R, Ling D, et al. [Preparation method of pH-sensitive nano Bcl-2 selective inhibitor and product and application]. CN 106822916 A. 2017."},{"key":"CIT0088","unstructured":"Yuan S, Chan FWJ, Yuen KY, et al. Zika virus protease inhibitors and methods of use thereof. WO 2018\/192083 A1. 2018."},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1208"},{"key":"CIT0090","volume-title":"Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information","author":"iCn3D","year":"2016"},{"key":"CIT0091","author":"Coleman P","journal-title":"Nat Commun"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2019.1627327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:29:50Z","timestamp":1721348990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2019.1627327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,7]]},"references-count":72,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,6,26]]},"published-print":{"date-parts":[[2019,7,3]]}},"alternative-id":["10.1080\/13543776.2019.1627327"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2019.1627327","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}